Ulrich Kaiser Selected Research

Ulrich Kaiser Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 09/2020
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2021
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2016 - 11/2002
4	Lymphoma (Lymphomas) 01/2016 - 11/2002
3	Infections 01/2016 - 04/2013
2	Leukemia 04/2024 - 07/2023
2	COVID-19 01/2022 - 01/2021
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016 - 04/2013
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 03/2024
1	Systemic Mastocytosis 03/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Pain (Aches) 12/2015
1	Fever (Fevers) 12/2015
1	Pneumonia (Pneumonitis) 12/2015
1	Exanthema (Rash) 12/2015
1	Hemorrhage 12/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2015
1	Cardiotoxicity 01/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2014
1	Stomatitis 04/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2013
1	Alopecia (Baldness) 04/2013

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 11/2023 - 10/2006
3	Vincristine (Oncovin)FDA LinkGeneric 01/2014 - 11/2002
3	Prednisone (Sone)FDA LinkGeneric 01/2014 - 11/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014 - 11/2002
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2023 - 10/2006
2	Bendamustine Hydrochloride FDA Link 01/2016 - 04/2013
2	Etoposide (VP 16)FDA LinkGeneric 01/2014 - 11/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2013 - 11/2002
1	venetoclaxIBA 04/2024
1	Contrast MediaIBA 01/2024
1	Complement System Proteins (Complement)IBA 12/2023
1	Bevacizumab (Avastin)FDA Link 11/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	CohesinsIBA 01/2023
1	tyramine-deoxysorbitolIBA 01/2023
1	ChromatinIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	CPX-351IBA 10/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	N 30IBA 01/2021
1	Diphosphonates (Bisphosphonates)IBA 09/2020
1	fludarabineIBA 01/2016
1	purineIBA 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 12/2015
1	Phospholipases (Phospholipase)IBA 04/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014
1	4-demethoxyanthracyclineIBA 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 10/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2002

Therapy/Procedure

10	Therapeutics 04/2024 - 11/2002
6	Drug Therapy (Chemotherapy) 09/2020 - 06/2007
2	Radiotherapy 09/2020 - 11/2002
2	Stem Cell Transplantation 09/2016 - 06/2007
1	Cell Transplantation 03/2024
1	Palliative Care (Palliative Therapy) 01/2023
1	Ambulatory Care (Outpatient Care) 01/2022
1	Length of Stay 01/2022
1	Erythrocyte Transfusion 09/2020
1	Salvage Therapy 10/2006